We have limited information about the reported deaths of 30 elderly people in Norway who had received the Pfizer COVID vaccine. Here's what we do know.
Health-care workers wait in line at a COVID-19 vaccine clinic in Toronto on Jan. 7, 2021.
THE CANADIAN PRESS/Nathan Denette
Rollout of COVID-19 vaccines has begun. But getting the jab doesn't mean abandoning masks, distancing and handwashing. Here's why the current preventive measures must continue post-vaccine.
A woman reacts after receiving the vaccine outside the Ashton Gate stadium in Bristol, which has become a COVID-19 vaccination centre.
EPA-EFE
In our first weekly update on COVID vaccines, we consider how roll-out plans are being tweaked and when it's likely we'll start to see vaccines having an impact.
The best approach for protecting everyone’s health will require us to provide different vaccines to different people according to need and availability.
With vaccine shortages looming, experts are debating whether it is important to receive two doses or whether it's better to give one dose to more people and give a second when the supply is better.
I am a physician, and I just got my first shot of the Pfizer COVID-19 vaccine.
William Petri
With vaccines forthcoming for most Americans, many groups, including expectant mothers, are wondering if the vaccine is safe for them and their babies. A physician-scientist explains.
The French government will not accept any passengers arriving from the U.K. amid fears over the new mutant coronavirus strain.
Steve Parsons/PA Images via Getty Images
A new strain of the SARS-CoV-2 virus that causes COVID-19 appears to be spreading fast in the UK. This probably isn't a big problem, but the data isn't in yet.
A dose of the Pfizer vaccine being prepared to be given to a health worker in California, USA.
EPA-EFE
Experts from across The Conversation assess the work that's helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
The number one scientific breakthrough for 2020: multiple vaccines to prevent COVID-19.
Philippe Raimbault/Photodisc via Getty Images
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
Sandra Lindsay, a nurse at Long Island Jewish Medical Center, is given the COVID-19 vaccine – she is one of the first in the US to receive it.
EPA/Mark Lennihan
Vaccine hesitancy is not new, but it has a new element: few people can remember the devastating impact of diseases such as smallpox and polio and it is hard to see the lives saved by vaccination.
It may be many months before COVID control measures can be eased.
A nurse prepares a shot for a clinical trial of a COVID-19 vaccine candidate developed by the National Institutes of Health and Moderna Inc., on July 27, 2020 in Binghamton, N.Y.
(AP Photo/Hans Pennink, File)
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Now there is a third possible vaccine for fighting the COVID-19 pandemic.
Jakub Porzycki/NurPhoto via Getty Images
There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.
The pandemic rages as the world waits for COVID-19 vaccines.
Peter Zelei Images/Getty Images